Recombinant Human Galactosylceramidase/GALC Protein, CF

R&D Systems | Catalog # 7310-GH

R&D Systems
Loading...

Key Product Details

  • R&D Systems CHO-derived Recombinant Human Galactosylceramidase/GALC Protein (7310-GH)
  • Quality control testing to verify active proteins with lot specific assays by in-house scientists
  • All R&D Systems proteins are covered with a 100% guarantee

Source

CHO

Accession Number

Applications

Enzyme Activity
Loading...

Product Specifications

Source

Chinese Hamster Ovary cell line, CHO-derived human Galactosylceramidase/GALC protein
Met1-Arg685, with a C-terminal 6-His tag

Purity

>85%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

Endotoxin Level

<1.0 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Tyr43

Predicted Molecular Mass

74 kDa

SDS-PAGE

70-85 kDa, reducing conditions

Activity

Measured by its ability to cleave a fluorogenic substrate, 4-Methylumbelliferyl-beta -D-galactopyranoside.
The specific activity is >550 pmol/min/ug, as measured under the described conditions.

Reviewed Applications

Read 1 review rated 5 using 7310-GH in the following applications:

Scientific Data Images for Recombinant Human Galactosylceramidase/GALC Protein, CF

Recombinant Human Galactosylceramidase/GALC Protein Enzyme Activity Diagram.

Recombinant Human Galactosylceramidase/GALC Protein Enzyme Activity Diagram. Recombinant Human Galactosylceramidase/GALC Protein, CF (Catalog # 7310-GH) catalyzes the hydrolysis of beta -d-galactocerebroside to beta -d-galactose and ceramide.

Recombinant Human Galactosylceramidase/GALC Protein Enzyme Activity.

Recombinant Human Galactosylceramidase/GALC Protein, CF (Catalog # 7310-GH) is measured by its ability to cleave a fluorogenic substrate, 4-Methylumbelliferyl-beta -D-galactopyranoside.

Recombinant Human Galactosylceramidase/GALC Protein SDS-PAGE.

2 μg/lane of Recombinant Human Galactosylceramidase/GALC Protein (Catalog # 7310-GH) was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by Coomassie® Blue staining, showing bands at 70-85 kDa.

Formulation, Preparation, and Storage

7310-GH
Formulation Supplied as a 0.2 μm filtered solution in MES, NaCl and Glycerol.
Shipping The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 6 months from date of receipt, -20 to -70 °C as supplied.
  • 3 months, -20 to -70 °C under sterile conditions after opening.

Background: Galactosylceramidase/GALC

Galactosylceramidase (GALC or galactocerebrosidase) is a lysosomal enzyme that hydrolyzes the galactose ester bonds of galactosylceramide, galactosylsphingosine, lactosylceramide, and monogalactosyldiglyceride, molecules that are important in the production of normal myelin (1). Mutations in the GALC gene have been associated with Krabbe’s Disease, also known as globoid cell leukodystrophy (2, 3, 4), a fatal autosomal recessive disorder resulting from the insufficient catabolism of these galactolipids. Krabbe’s Disease is morphologically characterized by almost total absence of myelin, severe gliosis, and the presence of characteristic multinucleated globoid cells in the white matter (4). In a recent study, cord blood transplants have been successful in stopping the disease (5).

References

  1. Chen, Y.Q. et al. (1993) Hum. Mol. Genet. 2:1841.
  2. Tappino, B. et al. (2010) Hum. Mutat. 31:E1894.
  3. Kodama, S. et al. (1982) J Neurochem. 39:1314.
  4. Suzuki, K. and Suzuki, Y. (1970) Proc. Natl. Acad. Sci. U.S.A. 66:302.
  5. Escolar, M.L. et al. (2005) N. Engl. J. Med. 352:2069.

Alternate Names

Galactocerebrosidase, Galactocerebroside beta-galactosidase, Galactosylceraminidase, GALC

Entrez Gene IDs

2581 (Human); 14420 (Mouse); 314360 (Rat)

Gene Symbol

GALC

UniProt

Additional Galactosylceramidase/GALC Products

Product Documents for Recombinant Human Galactosylceramidase/GALC Protein, CF

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Recombinant Human Galactosylceramidase/GALC Protein, CF

For research use only

Citations for Recombinant Human Galactosylceramidase/GALC Protein, CF

Customer Reviews for Recombinant Human Galactosylceramidase/GALC Protein, CF (1)

5 out of 5
1 Customer Rating
5 Stars
100%
4 Stars
0%
3 Stars
0%
2 Stars
0%
1 Stars
0%

Have you used Recombinant Human Galactosylceramidase/GALC Protein, CF?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 Yen for a review with an image

$10/€7/£6/$10CAN/¥1110 Yen for a review without an image

Submit a review
Amazon Gift Card
Showing  1 - 1 of 1 review Showing All
Filter By:
  • Recombinant Human Galactosylceramidase/GALC Protein, CF
    Name: Anonymous
    Application: Enzymatic activity in vitro
    Verified Customer | Posted 05/23/2016

There are no reviews that match your criteria.

Showing  1 - 1 of 1 review Showing All

Protocols

View specific protocols for Recombinant Human Galactosylceramidase/GALC Protein, CF (7310-GH):

Materials
  • Assay Buffer: 50 mM Sodium Citrate, 125 mM NaCl, 0.5% Triton® X-100, pH 4.5
  • Stop Solution: 0.5 M Glycine, 0.3 M NaOH (~pH 10.0)
  • Recombinant Human Galactosylceramidase/GALC (rhGALC) (Catalog # 7310-GH)
  • Substrate: 4-methylumbelliferyl-beta -D-galactopyranoside (Sigma, Catalog # M1633), 10 mM stock in DMSO
  • F16 Black Maxisorp Plate (Nunc, Catalog # 475515)
  • Fluorescent Plate Reader (Model: SpectraMax Gemini EM by Molecular Devices) or equivalent
  1. Dilute rhGALC to 0.06 ng/μL in Assay Buffer.
  2. Dilute Substrate to 1 mM in Assay Buffer.
  3. Load in a plate 25 μL of 0.06 ng/μL rhGALC, and start the reaction by adding 25 μL of 1 mM Substrate.  Include a Substrate Blank containing 25 μL of Assay Buffer and 25 μL of 1 mM Substrate.
  4. Seal plate and incubate at 37 °C for 20 minutes.
  5. After incubation, stop the reactions by adding 50 μL of Stop Solution to each well.
  6. Read at excitation and emission wavelengths of 365 nm and 445 nm (top read), respectively, in endpoint mode.
  7. Calculate specific activity: 

     Specific Activity (pmol/min/µg) =

Adjusted Fluorescence* (RFU) x Conversion Factor** (pmol/RFU)
Incubation time (min) x amount of enzyme (µg)

     *Adjusted for Substrate Blank
     **Derived using calibration standard 4-methylumbelliferone (Sigma, Catalog # M1381).

Per Well:
  • rhGALC: 0.0015 μg
  • Substrate: 0.25 mM

FAQs

No product specific FAQs exist for this product.

View all FAQs for Proteins and Enzymes